[Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lome] NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lome]

Bull Soc Pathol Exot. 2000 Feb;93(1):3-5. Unique Identifier : AIDSLINE MED/20236297
Balogou AA; Grunitzky EK; Anani TK; Kowu A; Sadzo-Hetsu A; Nubukpo KA; Dumas M; Service de neurologie, CHU, Lome, Togo.; abalogou@syfed.tg.refer.org


Abstract: The aim of this study was to determine the prevalence of Human T cell Leukaemia Virus Type 1 (HTLV1) in a representative population sample, in neurological and non-neurological patients hospitalised in the Lome teaching hospital in order to study the clinical manifestations of this retrovirus. There was no statistical difference among the three groups concerning the prevalence of HTLV1 respectively (1.2%: 21/1717, 1.8%: 15/828 and 1.6%: 4/244). Spastic paraparesis was the only disease significantly linked to HTLV1 (15.5%: 9/58).


Keywords: JOURNAL ARTICLE (prefecture de la Kozah et CHU de Lome). Adolescence Adult Aged Antibodies, Viral/BLOOD English Abstract Female Human HIV Antibodies/BLOOD *HTLV-I/IMMUNOLOGY HTLV-I Infections/*EPIDEMIOLOGY Male Middle Age Paraparesis, Spastic/VIROLOGY Togo/EPIDEMIOLOGYKWDjournalarticle(prefecturedelakozahetchudelome)KWDadolescenceadultagedantibodies,viral/bloodenglishabstractfemalehumanhivantibodies/bloodKWDhtlv-i/immunologyhtlv-iinfections/KWDepidemiologymalemiddleageparaparesis,spastic/virologytogo/epidemiology
000730
A0071466

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .